A DIVISION OF GENESIS DRUG DISCOVERY Trademark

Trademark Overview

On Wednesday, January 2, 2019, a trademark application was filed for A DIVISION OF GENESIS DRUG DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the A DIVISION OF GENESIS DRUG DISCOVERY trademark a serial number of 88246818. The federal status of this trademark filing is REGISTERED as of Tuesday, February 7, 2023. This trademark is owned by Genesis Biotechnology Group, LLC. The A DIVISION OF GENESIS DRUG DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
a division of genesis drug discovery

General Information

Serial Number88246818
Word MarkA DIVISION OF GENESIS DRUG DISCOVERY
Filing DateWednesday, January 2, 2019
Status700 - REGISTERED
Status DateTuesday, February 7, 2023
Registration Number6974747
Registration DateTuesday, February 7, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Description of MarkThe mark consists of the stylized term "GENESIS" below the phrase "A DIVISION OF" and above the phrase "DRUG DISCOVERY" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letter "GENES" and "S" in "GENESIS"; the colors beige and white appear in the fourteen spheres representing atoms; the color black appears in the phrases "A DIVISION OF" and "DRUG DISCOVERY", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.
Indication of Colors claimedThe color(s) maroon, beige, black and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"A DIVISION OF" AND "DRUG DISCOVERY"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 23, 2019
Primary Code042
First Use Anywhere DateSaturday, October 1, 2022
First Use In Commerce DateSaturday, October 1, 2022

Trademark Owner History

Party NameGenesis Biotechnology Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesis Biotechnology Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesis Biotechnology Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 7, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 3, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, October 31, 2022USE AMENDMENT FILED
Monday, October 31, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 11, 2022SOU EXTENSION 5 GRANTED
Tuesday, April 5, 2022SOU EXTENSION 5 FILED
Tuesday, April 5, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2021SOU EXTENSION 4 GRANTED
Thursday, October 28, 2021SOU EXTENSION 4 FILED
Thursday, October 28, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 29, 2021SOU EXTENSION 3 GRANTED
Tuesday, April 27, 2021SOU EXTENSION 3 FILED
Tuesday, April 27, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2020SOU EXTENSION 2 GRANTED
Thursday, October 15, 2020SOU EXTENSION 2 FILED
Thursday, October 15, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020SOU EXTENSION 1 GRANTED
Tuesday, April 14, 2020SOU EXTENSION 1 FILED
Monday, April 20, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 14, 2020SOU TEAS EXTENSION RECEIVED
Monday, April 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 13, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 5, 2019ASSIGNED TO LIE
Saturday, July 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, March 21, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, March 21, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, March 21, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Thursday, January 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 5, 2019NEW APPLICATION ENTERED

Related Keywords

discovery drug genesis division fields biotechnology pharmaceutical development research